Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Jazz Pharmaceuticals PLC (JAZZ) had Tangible Shareholders Equity of $-2.30B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$897.84M |
|
$-92.54M |
|
$104.62M |
|
$793.22M |
|
$953.73M |
|
$-55.89M |
|
$-53.92M |
|
$-109.81M |
|
$-109.81M |
|
$-92.00M |
|
$-92.54M |
|
$-92.54M |
|
$-92.00M |
|
$-55.89M |
|
$108.98M |
|
60.98M |
|
60.98M |
|
$-1.52 |
|
$-1.52 |
|
| Balance Sheet Financials | |
$4.13B |
|
$178.87M |
|
$7.41B |
|
$11.53B |
|
$1.22B |
|
$5.34B |
|
$6.14B |
|
$7.36B |
|
$4.17B |
|
|
Tangible Shareholders Equity |
$-2.30B |
$4.17B |
|
61.62M |
|
| Cash Flow Statement Financials | |
$429.78M |
|
$-168.93M |
|
$-813.47M |
|
$2.41B |
|
$1.86B |
|
$-550.92M |
|
$67.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.38 |
|
-- |
|
-- |
|
0.56 |
|
1.29 |
|
88.35% |
|
-6.23% |
|
-6.23% |
|
-- |
|
-12.23% |
|
-10.31% |
|
$415.90M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.21 |
|
1.38 |
|
65.46 |
|
-2.22% |
|
4.02% |
|
-0.80% |
|
-0.97% |
|
$67.75 |
|
$6.82 |
|
$7.05 |
|